Clinical Trial Update: Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating filanesib (ARRY-520) in combination with pomalidomide and dexamethasone for relapsed/refractory multiple myeloma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Filanesib (filanesib)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED